BMJ Open:“新计算器”助力临床医师精准诊断糖尿病分型

2019-10-09 国际糖尿病编辑部 国际糖尿病

精准确诊患者的糖尿病分型在糖尿病诊疗中举足轻重,是临床工作中的难点之一。由于患者临床特征的复杂性,尽管胰岛细胞相关的抗体检测、1型糖尿病遗传风险在一定程度上有助于诊断,却并不能做到精准诊断。 近期发表于BMJ OPEN杂志的一项研究显示一种在线使用的“新计算器”有助于快速诊断不同类型的糖尿病。

精准确诊患者的糖尿病分型在糖尿病诊疗中举足轻重,是临床工作中的难点之一。由于患者临床特征的复杂性,尽管胰岛细胞相关的抗体检测、1型糖尿病遗传风险在一定程度上有助于诊断,却并不能做到精准诊断。 近期发表于BMJ OPEN杂志的一项研究显示一种在线使用的“新计算器”有助于快速诊断不同类型的糖尿病。

本计算器在线使用糖尿病鉴别分型诊断模型

来自英国埃克塞特大学、牛津大学和邓迪大学共同联合开发了这种“新计算器”帮助临床医生快速诊断1型糖尿病(T1DM)或2型糖尿病 (T2DM),以指导临床医生采取最佳治疗方案,减少糖尿病并发症发生。“新计算器”是基于多变量临床诊断模型,纳入了患者的临床特征(诊断年龄、体质指数等)和临床生物标志物(谷氨酸脱羧酶抗体GADA、胰岛抗原2胰岛自身抗体,T1DM遗传风险评分)五个预测变量,以快速鉴别糖尿病的不同分型,减少误诊。

这项研究共纳入了1352例糖尿病患者用于多变量临床诊断模型的开发,582例糖尿病患者用于多变量临床诊断模型的验证,研究对象均为欧洲白人,年龄为18~50岁。T1DM诊断标准为快速的胰岛素需求(诊断后3年内)和严重内源性胰岛素缺乏(C肽<200pmol/l),T2DM诊断标准为短期内无胰岛素需求,或胰岛素治疗3年内保留内源性胰岛素分泌功能(C肽>600pmol/L,糖尿病病程≥5年)。

研究结果显示,模型开发队列中有13%的受试者为T1DM,五个预测变量均为T1DM的独立判别预测因子(P<0.001),个体接受者运行曲线下面积(ROC AUC)为0.82~0.85。多变量临床诊断模型预测准确性高,ROC AUC范围为0.90(95%CI为0.88~0.93)(仅临床特征)至0.97(95% CI为0.96-0.98)(所有预测因子),且预测误差低。多变量临床诊断模型的验证结果与预测结果保持一致,临床特征和GADA标志物预测ROC AUC为0.93(0.90~0.96)(图1)。结合临床特征和生物标志物的多变量临床诊断模型识别具有快速胰岛素需求的T1DM准确性高,可帮助临床医生和研究者准确地识别T1DM患者。




图1:新计算器研发样本验证结果情况

“新计算器”基于埃克塞特大学前期开发的相似计算器,帮助临床医生诊断患者是否为单一基因引起的糖尿病亚型MODY。目前在线计算器使用人群已经超过10万人,且9000余人下载了糖尿病诊断应用,这些数据将在“新计算器”中得以更新。近期,巴塞罗那召开的欧洲糖尿病研究协会年会(EASD2019)上发表的一项新研究表明,约半数转诊至英国诊断实验室的MODY病例使用过“计算器”,并且使用“计算器”较未使用计算器的病例检出率更高。

负责这项研究的埃克塞特大学医学院Angus Jones博士表示,“糖尿病的正确诊断对其治疗和预后至关重要,不同类型糖尿病的治疗方案相去甚远。然而,在临床实践中,部分患者很难被明确诊断其糖尿病分型,”新计算器“可以帮助临床医生综合临床特征及生物标记物,以评估T1DM的可能性,并指导进行进一步的检测以明确诊断。”

在线计算器:

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1804270, encodeId=964d18042e0fe, content=<a href='/topic/show?id=be8ce667717' target=_blank style='color:#2F92EE;'>#糖尿病分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76677, encryptionId=be8ce667717, topicName=糖尿病分型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Jun 12 20:47:00 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728159, encodeId=a0541e2815993, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Jun 29 06:47:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812833, encodeId=a435181283326, content=<a href='/topic/show?id=581191148bc' target=_blank style='color:#2F92EE;'>#计算器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91148, encryptionId=581191148bc, topicName=计算器)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 13 01:47:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848866, encodeId=f3ec184886640, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 08 00:47:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403452, encodeId=96ab1403452d3, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Oct 11 12:47:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042756, encodeId=61711042e5641, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Oct 10 00:47:00 CST 2019, time=2019-10-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1804270, encodeId=964d18042e0fe, content=<a href='/topic/show?id=be8ce667717' target=_blank style='color:#2F92EE;'>#糖尿病分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76677, encryptionId=be8ce667717, topicName=糖尿病分型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Jun 12 20:47:00 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728159, encodeId=a0541e2815993, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Jun 29 06:47:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812833, encodeId=a435181283326, content=<a href='/topic/show?id=581191148bc' target=_blank style='color:#2F92EE;'>#计算器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91148, encryptionId=581191148bc, topicName=计算器)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 13 01:47:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848866, encodeId=f3ec184886640, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 08 00:47:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403452, encodeId=96ab1403452d3, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Oct 11 12:47:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042756, encodeId=61711042e5641, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Oct 10 00:47:00 CST 2019, time=2019-10-10, status=1, ipAttribution=)]
    2020-06-29 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1804270, encodeId=964d18042e0fe, content=<a href='/topic/show?id=be8ce667717' target=_blank style='color:#2F92EE;'>#糖尿病分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76677, encryptionId=be8ce667717, topicName=糖尿病分型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Jun 12 20:47:00 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728159, encodeId=a0541e2815993, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Jun 29 06:47:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812833, encodeId=a435181283326, content=<a href='/topic/show?id=581191148bc' target=_blank style='color:#2F92EE;'>#计算器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91148, encryptionId=581191148bc, topicName=计算器)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 13 01:47:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848866, encodeId=f3ec184886640, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 08 00:47:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403452, encodeId=96ab1403452d3, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Oct 11 12:47:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042756, encodeId=61711042e5641, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Oct 10 00:47:00 CST 2019, time=2019-10-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1804270, encodeId=964d18042e0fe, content=<a href='/topic/show?id=be8ce667717' target=_blank style='color:#2F92EE;'>#糖尿病分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76677, encryptionId=be8ce667717, topicName=糖尿病分型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Jun 12 20:47:00 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728159, encodeId=a0541e2815993, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Jun 29 06:47:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812833, encodeId=a435181283326, content=<a href='/topic/show?id=581191148bc' target=_blank style='color:#2F92EE;'>#计算器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91148, encryptionId=581191148bc, topicName=计算器)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 13 01:47:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848866, encodeId=f3ec184886640, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 08 00:47:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403452, encodeId=96ab1403452d3, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Oct 11 12:47:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042756, encodeId=61711042e5641, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Oct 10 00:47:00 CST 2019, time=2019-10-10, status=1, ipAttribution=)]
    2020-04-08 gaoxiaoe
  5. [GetPortalCommentsPageByObjectIdResponse(id=1804270, encodeId=964d18042e0fe, content=<a href='/topic/show?id=be8ce667717' target=_blank style='color:#2F92EE;'>#糖尿病分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76677, encryptionId=be8ce667717, topicName=糖尿病分型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Jun 12 20:47:00 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728159, encodeId=a0541e2815993, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Jun 29 06:47:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812833, encodeId=a435181283326, content=<a href='/topic/show?id=581191148bc' target=_blank style='color:#2F92EE;'>#计算器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91148, encryptionId=581191148bc, topicName=计算器)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 13 01:47:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848866, encodeId=f3ec184886640, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 08 00:47:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403452, encodeId=96ab1403452d3, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Oct 11 12:47:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042756, encodeId=61711042e5641, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Oct 10 00:47:00 CST 2019, time=2019-10-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1804270, encodeId=964d18042e0fe, content=<a href='/topic/show?id=be8ce667717' target=_blank style='color:#2F92EE;'>#糖尿病分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76677, encryptionId=be8ce667717, topicName=糖尿病分型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Jun 12 20:47:00 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728159, encodeId=a0541e2815993, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Jun 29 06:47:00 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812833, encodeId=a435181283326, content=<a href='/topic/show?id=581191148bc' target=_blank style='color:#2F92EE;'>#计算器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91148, encryptionId=581191148bc, topicName=计算器)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 13 01:47:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848866, encodeId=f3ec184886640, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 08 00:47:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403452, encodeId=96ab1403452d3, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Oct 11 12:47:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042756, encodeId=61711042e5641, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Oct 10 00:47:00 CST 2019, time=2019-10-10, status=1, ipAttribution=)]
    2019-10-10 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Circulation:载脂蛋白AI可促进动脉粥样硬化消退

虽然糖尿病患者的胆固醇水平显著降低,但其心血管疾病风险仍在增加。与此一致,糖尿病对人和小鼠胆固醇降低后的动脉粥样硬化消退过程有损害作用。在小鼠中,这在一定程度上归因于高血糖诱导的单核细胞增多症,增加了单核细胞进入斑块的机会,尽管胆固醇水平降低了。此外,糖尿病使斑块巨噬细胞向致动脉粥样硬化的炎性M1表型转化,而不是典型的伴有胆固醇降低的促动脉粥样硬化溶解的M2状态。在糖尿病患者中水平一般较低的功能性

奥马环素治疗糖尿病ABSSSI患者安全有效

根据2019年美国传染病学会年会上发表的一项研究表明,无论糖尿病状态如何,奥马环素(Omadacycline)对患有急性细菌性皮肤结构感染(ABSSSI)的患者都是安全有效的。

2型糖尿病及心血管疾病风险:男女有何差异?Why?

根据2018年IDF糖尿病地图估计,2017年全球糖尿病患者高达4.25亿人,其中男性2.21亿,女性2.04亿。既往流行病学研究显示:青少年和中年时期2型糖尿病的患病率存在明显的性别差异,而且也发现2型糖尿病患者对CVD结局的影响亦存在性别差异。今天分享的这篇综述,主要总结了年龄和发育阶段如何影响两项公认存在性别差异的领域:1)糖尿病患病率的差异,特别是在青春期和中年期;2) 2型糖尿病带来

Clin Chem:中美研究人员开发出糖尿病并发症快速检测方法

​中美两国科研人员开发出一种快速、精确检测糖尿病并发症的方法,只需几滴血,即可发现糖尿病病人是否出现心脏病、动脉粥样硬化和肾衰竭等危及生命的并发症。

JCEM:糖尿病成年患者体重变化后心血管疾病和死亡风险

由此可见,在没有实质性生活方式改变的情况下,体重减轻可能是健康状况不佳的警告信号,需要对2型糖尿病患者进行进一步检查。

Eye:贫血增加糖尿病并发症风险,病友们赶紧补起来吧!

糖尿病视网膜病变(DR)是2型糖尿病(T2DM)最常见的微血管并发症之一,据统计,我国每年有300-400 万糖尿病患者因DR出现失明,DR严重威胁着糖尿病患者的生存质量,同时给社会带来严重经济负担,早期预防T2DM引起的微血管变化是治疗糖尿病的重要目标。